Published in Brain Res on May 18, 1979
Opiate antagonistic properties of an octapeptide somatostatin analog. Proc Natl Acad Sci U S A (1982) 0.98
Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ (1999) 4.98
Predictive testing for Huntington's disease with use of a linked DNA marker. N Engl J Med (1988) 3.82
Relationship between the cytoplasm and the vacuole phosphate pool in Acer pseudoplatanus cells. Arch Biochem Biophys (1983) 3.39
A radioimmunoassay for human prolactin. Proc Natl Acad Sci U S A (1971) 3.36
Academic relationships with industry: a new model for biomedical research. JAMA (2001) 3.15
Huntington's disease. Pathogenesis and management. N Engl J Med (1986) 2.77
Biochemical changes during sucrose deprivation in higher plant cells. Phosphorus-31 nuclear magnetic resonance studies. J Biol Chem (1987) 2.58
Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest (1998) 2.41
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. Proc Natl Acad Sci U S A (1982) 2.38
Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature (1986) 2.29
Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr (1975) 2.25
Selective sparing of a class of striatal neurons in Huntington's disease. Science (1985) 2.16
Patient-oriented research: principles and new approaches to training. Am J Med (2000) 1.90
Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology (1976) 1.76
Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med (1978) 1.76
Transient accumulation of asparagine in sycamore cells after a long period of sucrose starvation. Plant Physiol (1990) 1.64
Simulation-based occupancy recommendations for adult medical/surgical units using admissions scheduling systems. Inquiry (1978) 1.62
Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology (1988) 1.62
Identification of factors associated with hospital readmission and development of a predictive model. Health Serv Res (1992) 1.58
Danger of using core/peripheral temperature gradient as a guide to therapy in shock. Crit Care Med (1987) 1.55
Women's attitudes toward careers in academic medicine at the University of California, San Francisco. Acad Med (1992) 1.54
Effect of sucrose starvation on sycamore (Acer pseudoplatanus) cell carbohydrate and Pi status. Biochem J (1985) 1.53
Depressant action of TRH, LH-RH and somatostatin on activity of central neurones. Nature (1975) 1.50
Evaluation of healthcare software from a usability perspective. J Med Syst (1990) 1.46
Preliminary results on the mental development of hypothyroid infants detected by the Quebec Screening Program. J Pediatr (1983) 1.46
Follow-up at ages 5 and 7 years on mental development in children with hypothyroidism detected by Quebec Screening Program. J Pediatr (1985) 1.46
Surgical demand scheduling: a review. Health Serv Res (1978) 1.44
Modification of a screening program for neonatal hypothyroidism. J Pediatr (1978) 1.44
Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol (1993) 1.43
Intraorbital ophthalmic artery aneurysm associated with basilar tip saccular aneurysm. Neuroradiology (2002) 1.43
Rapid cooling contracture with cold cardioplegia. Ann Thorac Surg (1997) 1.43
Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med (1981) 1.41
Conference report: community-based health promotion--state of the art and recommendations for the future. Am J Prev Med (1997) 1.41
MOM-mobile brings ultrasounds to moms. Am J Public Health (1991) 1.39
Purification of human prolactin. J Biol Chem (1972) 1.37
Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients. J Natl Cancer Inst (1990) 1.34
The hypothalamus in pituitary-thyroid regulation. Recent Prog Horm Res (1972) 1.33
Somatostatin analogue SMS 201-995 reduces serum IGF-I levels in patients with neoplasms potentially dependent on IGF-I. Anticancer Res (1989) 1.33
Immunologic evidence for monkey and human prolactin (MPr and HPr). J Clin Endocrinol Metab (1971) 1.30
Intravenous sedation in accident and emergency departments: a nationwide survey. Ann R Coll Surg Engl (1994) 1.30
An evaluation of telemedical support for a minor treatment centre. J Telemed Telecare (1996) 1.28
Dense packing of cerebral aneurysms: an in vitro study with detachable platinum coils. AJNR Am J Neuroradiol (2000) 1.26
Thyroid function in neonatal hypothyroidism. J Pediatr (1976) 1.24
Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab (1975) 1.23
Centrally mediated orthostatic hypotension. Report of cases. Arch Neurol (1968) 1.23
Functional evaluation of prolactin secretion: a guide to therapy. J Clin Invest (1972) 1.22
D-lactic acidosis simulating a hypothalamic syndrome after bowel bypass. Ann Neurol (1982) 1.20
Breaking down the walls: thoughts on the scholarship of integration. Acad Med (2000) 1.18
Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry (1985) 1.18
Neural regulation of growth hormone secretion. N Engl J Med (1973) 1.17
Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest (1994) 1.16
Brain peptides (first of two parts). N Engl J Med (1981) 1.16
Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol (1972) 1.15
TSH measurements from blood spots on filter paper: a confirmatory screening test for neonatal hypothyroidism. J Pediatr (1976) 1.14
Pathology findings with acrylic implants. Bone (1999) 1.13
Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J Neuropathol Exp Neurol (1987) 1.12
Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease. Brain Res (1987) 1.11
Huntington's disease: new approaches to an old problem. The Robert Wartenberg lecture. Neurology (1984) 1.11
The physician as a locus of authority, responsibility, and operational control of medical systems. J Med Syst (1988) 1.11
Two types of somatostatin receptors differentiated by cyclic somatostatin analogs. Science (1985) 1.11
Parameters affecting hospital occupancy and implications for facility sizing. Health Serv Res (1978) 1.10
Biosynthesis of monkey growth hormone and prolactin in vitro. Endocrinology (1971) 1.10
Effects of nerve growth factor antiserum on peripheral unmyelinated nerve fibers. Acta Neuropathol (1972) 1.08
Esophageal motility in tracheoesophageal fistula and esophageal atresia. Surg Gynecol Obstet (1966) 1.08
Electrophysiological studies of connections of hypothalamic ventromedial nucleus neurons in the rat: evidence for a role in neuroendocrine regulation. Brain Res (1975) 1.07
Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary. Proc Natl Acad Sci U S A (1981) 1.06
Pituitary apoplexy. The importance of skull roentgenograms and computerized tomography in diagnosis. JAMA (1980) 1.04
Chromatographic and biological properties of immunoreactive somatostatin in hypothalamic and extrahypothalamic brain regions of the rat. Endocrinology (1979) 1.04
Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol (1985) 1.04
The biosynthesis of human growth hormone and prolactin. J Clin Endocrinol Metab (1970) 1.04
Contrasting patterns of Bim induction and neuroprotection in Bim-deficient mice between hippocampus and neocortex after status epilepticus. Cell Death Differ (2009) 1.03
Plasma melatonin increases during exercise in women. J Clin Endocrinol Metab (1981) 1.03
Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders. J Clin Invest (1973) 1.02
Endocrine abnormalities in thalassemia. Ann N Y Acad Sci (1990) 1.02
Radiation dose in vertebroplasty. Neuroradiology (2004) 1.01
Brain peptides (second of two parts). N Engl J Med (1981) 1.01
Subcellular distribution of radioimmunoassayable somatostatin in rat brain. Brain Res (1977) 1.01
Fatty acid analysis of blood serum, seminal plasma, and spermatozoa of normozoospermic vs. asthenozoospermic males. Lipids (1999) 1.01
Hypothalamic peptides: New evidence for "peptidergic" pathways in the C.N.S. Lancet (1975) 1.00
Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man. J Clin Endocrinol Metab (1975) 0.99
Light and electron microscopic localization of immunoreactive Leu-enkephalin in the monkey basal ganglia. J Neurosci (1982) 0.99
The pediatric disposable end-tidal carbon dioxide detector role in endotracheal intubation in newborns. J Perinatol (1999) 0.98
Huntington's disease: genetically programmed cell death in the human central nervous system. Nature (1982) 0.98
Serum luteinizing hormone by radioimmunoassay in normal children. J Pediatr (1969) 0.98
The autosomal dominant form of "pure" familial spastic paraplegia: clinical findings and linkage analysis of a large pedigree. Neurology (1987) 0.97
Thyrotropin releasing hormone (TRH): depressant action on central neuronal activity. Brain Res (1975) 0.97
PMMA cementoplasty in symptomatic metastatic lesions of the S1 vertebral body. Cardiovasc Intervent Radiol (2000) 0.96
Opiates, prolactin, and the dopamine receptor. J Clin Endocrinol Metab (1978) 0.96
Histologic, ultrastructural and hormonal characterization of a pituitary tumor secreting both HGH and prolactin. J Clin Endocrinol Metab (1973) 0.96
Suppression of androgen production by D-tryptophan-6-luteinizing hormone-releasing hormone in man. J Clin Invest (1981) 0.96
The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab (1998) 0.95
Pulsatile growth hormone secretion: suppression by hypothalamic ventromedial lesions and by long-acting somatostatin. Science (1974) 0.95
Cerebral lesions in familial amyotrophic lateral sclerosis and dementia. Acta Neuropathol (1973) 0.95
Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease. Science (1985) 0.95
Percutaneous transluminal angioplasty and stenting of the proximal vertebral artery for symptomatic stenosis. AJNR Am J Neuroradiol (2000) 0.94
Sexual ictal manifestations predominate in women with temporal lobe epilepsy: a finding suggesting sexual dimorphism in the human brain. Neurology (1983) 0.94
Phosphoethanolamine and ethanolamine are decreased in Alzheimer's disease and Huntington's disease. Brain Res (1987) 0.93